<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7703754</article-id>
    <article-id pub-id-type="pmid">31589304</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btz747</article-id>
    <article-id pub-id-type="publisher-id">btz747</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>γ-TRIS: a graph-algorithm for comprehensive identification of vector genomic insertion sites</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3515-3384</contrib-id>
        <name>
          <surname>Calabria</surname>
          <given-names>Andrea</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff1">1</xref>
        <xref ref-type="author-notes" rid="btz747-FM1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Beretta</surname>
          <given-names>Stefano</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff2">2</xref>
        <xref ref-type="aff" rid="btz747-aff3">3</xref>
        <xref ref-type="author-notes" rid="btz747-FM1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Merelli</surname>
          <given-names>Ivan</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff3">3</xref>
        <xref ref-type="author-notes" rid="btz747-FM1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Spinozzi</surname>
          <given-names>Giulio</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff1">1</xref>
        <xref ref-type="aff" rid="btz747-aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brasca</surname>
          <given-names>Stefano</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pirola</surname>
          <given-names>Yuri</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Benedicenti</surname>
          <given-names>Fabrizio</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tenderini</surname>
          <given-names>Erika</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bonizzoni</surname>
          <given-names>Paola</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Milanesi</surname>
          <given-names>Luciano</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Montini</surname>
          <given-names>Eugenio</given-names>
        </name>
        <xref ref-type="aff" rid="btz747-aff1">1</xref>
        <xref ref-type="corresp" rid="btz747-cor1"/>
        <!--<email>montini.eugenio@hsr.it</email>-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Berger</surname>
          <given-names>Bonnie</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="btz747-aff1"><label>1</label><institution>San Raffaele Telethon Institute for Gene Therapy (SR-Tiget)</institution>, IRCCS San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, <country country="IT">Italy</country></aff>
    <aff id="btz747-aff2"><label>2</label><institution>Università degli Studi di Milano Bicocca, Dipartimento di Informatica Sistemistica e Comunicazione (DiSCO)</institution>, Viale Sarca, 336, 20126, Milano, <country country="IT">Italy</country></aff>
    <aff id="btz747-aff3"><label>3</label><institution>National Research Council, Institute for Biomedical Technologies</institution>, Via Fratelli Cervi, 93, 20090, Segrate, <country country="IT">Italy</country></aff>
    <author-notes>
      <fn id="btz747-FM1">
        <p>The authors wish it to be known that, in their opinion, Andrea Calabria, Stefano Beretta and Ivan Merelli should be regarded as Joint First Authors.</p>
      </fn>
      <corresp id="btz747-cor1">To whom correspondence should be addressed. E-mail: <email>montini.eugenio@hsr.it</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <month>3</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2019-10-07">
      <day>07</day>
      <month>10</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>10</month>
      <year>2019</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>36</volume>
    <issue>5</issue>
    <fpage>1622</fpage>
    <lpage>1624</lpage>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>10</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>18</day>
        <month>9</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>01</day>
        <month>10</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btz747.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Retroviruses and their vector derivatives integrate semi-randomly in the genome of host cells and are inherited by their progeny as stable genetic marks. The retrieval and mapping of the sequences flanking the virus-host DNA junctions allows the identification of insertion sites in gene therapy or virally infected patients, essential for monitoring the evolution of genetically modified cells <italic>in vivo</italic>. However, since ∼30% of insertions land in low complexity or repetitive regions of the host cell genome, they cannot be correctly assigned and are currently discarded, limiting the accuracy and predictive power of clonal tracking studies. Here, we present γ-TRIS, a new graph-based genome-free alignment tool for identifying insertion sites even if embedded in low complexity regions. By using γ-TRIS to reanalyze clinical studies, we observed improvements in clonal quantification and tracking.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>Source code at <ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/bereste/g-tris">https://bitbucket.org/bereste/g-tris</ext-link>.</p>
      </sec>
      <sec id="s3">
        <title>Supplementary information</title>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Telethon Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100002426</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>TGT11D1</award-id>
        <award-id>TGT16B01</award-id>
        <award-id>TGT16B03</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>ISCRA</institution>
          </institution-wrap>
        </funding-source>
        <award-id>HP10CEUWXF</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Giovani Ricercatori</institution>
          </institution-wrap>
        </funding-source>
        <award-id>GR-2016-02363681</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>University and Research flagship initiative Interomics</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Viruses and retroviral vectors (RV) stably insert DNA sequences in the genome of the host cells in integration sites (IS) and provide a permanent and unique genetic mark for each independently transduced cell clone and its progeny. Several Gene Therapy (GT) applications exploit RV to add the therapeutic transgene in diseased target cells. Molecular studies using IS assessed the safety and long-term efficacy of hematopoietic stem and progenitor cell based GT applications using gamma-retroviral and lentiviral vectors (LV) by identifying and tracking thousands of IS across different hematopoietic lineages over time. Results from IS studies allowed to monitor clonal evolution <italic>in vivo</italic> (<xref rid="btz747-B8" ref-type="bibr">Naldini, 2015</xref>), including clonal expansions caused by insertional mutagenesis (<xref rid="btz747-B1" ref-type="bibr">Afzal <italic>et al.</italic>, 2017</xref>; <xref rid="btz747-B2" ref-type="bibr">Berry <italic>et al.</italic>, 2017</xref>; <xref rid="btz747-B9" ref-type="bibr">Sherman <italic>et al.</italic>, 2017</xref>; <xref rid="btz747-B10" ref-type="bibr">Spinozzi <italic>et al.</italic>, 2017</xref>). PCR-based or targeted enrichment techniques, combined with Next-Generation Sequencing and bioinformatics analyses, allow the retrieval and mapping of the cellular genomic sequences flanking the vector ISs present in the DNA extracted from vector marked cells. Most of the existing bioinformatics tools for IS identification return IS from reads aligned to unique genomic positions while reads with multiple hits are discarded or handled separately to generate basic information of ISs landing within repetitive elements (<xref rid="btz747-B1" ref-type="bibr">Afzal <italic>et al.</italic>, 2017</xref>; <xref rid="btz747-B2" ref-type="bibr">Berry <italic>et al.</italic>, 2017</xref>; <xref rid="btz747-B9" ref-type="bibr">Sherman <italic>et al.</italic>, 2017</xref>; <xref rid="btz747-B10" ref-type="bibr">Spinozzi <italic>et al.</italic>, 2017</xref>). The amount of IS that cannot be univocally mapped averages 30% of the entire dataset (<xref rid="btz747-B4" ref-type="bibr">Calabria <italic>et al.</italic>, 2014</xref>), therefore corresponds to a significant portion of patients’ IS. This could lead to miss potentially malignant clones caused by IS landing in repeats within or near oncogenes or to mis-quantify the abundance of each clone accounted as relative percentage of the IS on the overall set of IS. To identify the whole repertoire of IS in from sequence datasets of PCR products containing vector genome junctions, we developed γ-TRIS (Graph-based algorithm for Tracking Retroviral Insertion Sites).</p>
  </sec>
  <sec>
    <title>2 Design and implementation</title>
    <p>The basic idea of γ-TRIS is to identify IS from clusters of highly similar sequences as result of all-versus-all reads alignment, rather than a direct alignment against an indexed genome and then using a consensus sequence from each cluster as IS sequence to be mapped to the reference genome. γ-TRIS starts by aligning each unique sequence of the dataset to each other, identifying clusters of sequences containing vector-host genome junctions originating from the same IS represented by a graph structure (<xref ref-type="fig" rid="btz747-F1">Fig. 1A</xref>). To reduce the number of false IS, the graph is iteratively decomposed in sub-graphs of highly connected sequences and from each atomic (highly-connected) cluster a consensus sequence is computed and mapped against the reference genome. These consensus sequences are also searched for known genomic repetitive elements to annotate each cluster with all the available genomic information. All the alignment results and repeat annotations of the consensus sequences are used as labels of the corresponding predicted clusters. Then, γ-TRIS compares the annotation labels by rolling-back the decomposition graph structure and tries to merge clusters that likely represent the same IS. The reliability of each putative IS of being an independent cluster is statistically assessed through a heuristic permutation test, therefore allowing to further merge similar clusters and to associate an upper-bound <italic>P</italic>-value to each cluster (<italic>P</italic> &lt; 0.05). See <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Section S1 for development details.</p>
    <fig id="btz747-F1" orientation="portrait" position="float">
      <label>Fig. 1.</label>
      <caption>
        <p>γ-TRIS flowchart and comparative performances. (<bold>A</bold>) Schematic representation of the γ-TRIS pipeline and its graphical representation. (<bold>B</bold>) Scatter plots of average precision and recall for three tools on the simulated datasets. Background gradient color scale and contour lines are based on the F-score as indicated in the legend box. All tools have been tested with default parameters without any adjustments nor optimizations of the configurations for the specific simulated datasets, that could impact in the assessment of precision and recall. (<bold>C</bold>) MLD IS landing in repetitive elements within the main repeat classes SINE, LINE, LTR and DNA versus expected percentage under null hypothesis reflecting the proportion of repeats in the human genome</p>
      </caption>
      <graphic xlink:href="btz747f1"/>
    </fig>
  </sec>
  <sec>
    <title>3 Results</title>
    <p>We tested the reliability of γ-TRIS on simulated IS sequence datasets composed of 98 596 random coordinates as IS from the human genome (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Section S2). We compared the performances of γ-TRIS to those of the most recent IS mapping pipelines GENE-IS (<xref rid="btz747-B1" ref-type="bibr">Afzal <italic>et al.</italic>, 2017</xref>), INSPIIRED (<xref rid="btz747-B9" ref-type="bibr">Sherman <italic>et al.</italic>, 2017</xref>), VISPA (<xref rid="btz747-B10" ref-type="bibr">Spinozzi <italic>et al.</italic>, 2017</xref>) and UClust (<xref rid="btz747-B6" ref-type="bibr">Edgar, 2010</xref>), a heuristic clustering method recently exploited for IS analysis in HIV-1 patients (<xref rid="btz747-B7" ref-type="bibr">Maldarelli <italic>et al.</italic>, 2014</xref>; <xref rid="btz747-B11" ref-type="bibr">Wagner <italic>et al.</italic>, 2014</xref>) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Sections S3 and S4). To avoid introducing any biases in final IS results, we did not change the default parameters in all tested pipelines (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Section S3 for details), whose optimal configuration has been developed and released by Authors. However, further parameter optimization and tuning on the simulated datasets might produce more favorable results for the other methods. Statistical assessment exploited positive predictive values (or precision) and sensitivity (or recall) by considering an IS as true positive (TP) if correctly assigned to the source locus, false positive (FP) if misplaced in any other genomic loci and false negative (FN) if missing or not returned in the result list. For the dataset without mutations, γ-TRIS returned 98 152 IS of the total 98 596 IS, 98 147 of which (&gt;99.5%) were TPs, 5 FPs and 449 FNs, thus giving rise to an average recall of 0.994 and precision of 0.999, corresponding to the best F-score (&gt;0.997) (<xref ref-type="fig" rid="btz747-F1">Fig. 1B</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>). In the artificially mutagenized datasets, precision and recall decreased at different rates depending on the tool used, but γ-TRIS maintained the best F-score (0.99 with 0.25% of errors, dataset X and 0.973 with 0.5% of errors, dataset 2X), without major unbalancing of precision and recall when compared to other tools, even when high levels of sequence variations were introduced. To evaluate γ-TRIS results, we also generated <italic>in vitro</italic> experiments from a purified human cell line with six known IS (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>, Section S5). UClust identified only five out of six IS while γ-TRIS and the other IS tools identified all six known IS (mapping &gt;98% of the produced reads). We then re-analyzed the raw sequencing data from the published IS datasets of three GT patients of the LV-based clinical trial of Metachromatic Leukodystrophy (MLD), previously reported with VISPA to assess safety and efficacy of the treatment (<xref rid="btz747-B3" ref-type="bibr">Biffi <italic>et al.</italic>, 2013</xref>). MLD results with γ-TRIS, compared to those published (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S1</xref>), showed improvements in the overall number of IS (average fold increase of 1.29 among the three patients), in the amount of sequencing reads (average fold increase of 1.59) and in the number of recaptured IS over time or lineages (average fold increase of 1.38) important readouts to evaluate the HSC marking and tracking of cell clones across lineages and time. Interestingly, the diversity index of the clonal population did not change using γ-TRIS. The number of additional IS found by γ-TRIS corresponded to the previous amount of IS discarded by VISPA (∼30% of the total sequencing reads). Although the vast majority of the new IS identified by γ-TRIS could not be precisely mapped on the host genome, about 5% of those lost by VISPA could be univocally mapped thanks to the improved quality of the consensus sequences. Moreover, MLD IS in repeated regions showed a marked preference to target SINE-Alu repetitive elements (<xref ref-type="fig" rid="btz747-F1">Fig. 1C</xref>) as observed in a recent study of HIV-1 integration (<xref rid="btz747-B5" ref-type="bibr">Cohn <italic>et al.</italic>, 2015</xref>).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>btz747_Supplementary_Data</label>
      <media xlink:href="btz747_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors dedicate this work to the memory of all patients in San Raffaele Telethon Institute for Gene Therapy and their families, their hope is our strength. They are grateful to all the lab member of the Montini’s lab especially to Daniela Cesana. They finally thank CINECA for the ICT support.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by Telethon Foundation TGT11D1, TGT16B01 and TGT16B03 to EM; ISCRA Grant HP10CEUWXF 2015 and Giovani Ricercatori GR-2016-02363681 by the Ministry of Health to AC; University and Research flagship initiative Interomics (PB05) to LM.</p>
      <p><italic>Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btz747-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Afzal</surname><given-names>S.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>GENE-IS: time-efficient and accurate analysis of viral integration events in large-scale gene therapy data</article-title>. <source>Mol. Ther. Nucleic Acids</source>, <volume>6</volume>, <fpage>133</fpage>–<lpage>139</lpage>.<pub-id pub-id-type="pmid">28325279</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berry</surname><given-names>C.C.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>INSPIIRED: quantification and visualization tools for analyzing integration site distributions</article-title>. <source>Mol. Ther. Methods Clin. Dev</source>., <volume>4</volume>, <fpage>17</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">28344988</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biffi</surname><given-names>A.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy</article-title>. <source>Science</source>, <volume>341</volume>, <fpage>1233158</fpage>.<pub-id pub-id-type="pmid">23845948</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calabria</surname><given-names>A.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>VISPA: a computational pipeline for the identification and analysis of genomic vector integration sites</article-title>. <source>Genome Med</source>., <volume>6</volume>, <fpage>67</fpage>.<pub-id pub-id-type="pmid">25342980</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohn</surname><given-names>L.B.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>HIV-1 integration landscape during latent and active infection</article-title>. <source>Cell</source>, <volume>160</volume>, <fpage>420</fpage>–<lpage>432</lpage>.<pub-id pub-id-type="pmid">25635456</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edgar</surname><given-names>R.C.</given-names></name></person-group> (<year>2010</year>) 
<article-title>Search and clustering orders of magnitude faster than BLAST</article-title>. <source>Bioinformatics</source>, <volume>26</volume>, <fpage>2460</fpage>–<lpage>2461</lpage>.<pub-id pub-id-type="pmid">20709691</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maldarelli</surname><given-names>F.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells</article-title>. <source>Science</source>, <volume>345</volume>, <fpage>179</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">24968937</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naldini</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>) 
<article-title>Gene therapy returns to centre stage</article-title>. <source>Nature</source>, <volume>526</volume>, <fpage>351</fpage>–<lpage>360</lpage>.<pub-id pub-id-type="pmid">26469046</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherman</surname><given-names>E.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>INSPIIRED: a pipeline for quantitative analysis of sites of new DNA integration in cellular genomes</article-title>. <source>Mol. Ther. Methods Clin. Dev</source>., <volume>4</volume>, <fpage>39</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">28344990</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spinozzi</surname><given-names>G.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites</article-title>. <source>BMC Bioinformatics</source>, <volume>18</volume>, <fpage>520</fpage>.<pub-id pub-id-type="pmid">29178837</pub-id></mixed-citation>
    </ref>
    <ref id="btz747-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wagner</surname><given-names>T.A.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection</article-title>. <source>Science</source>, <volume>345</volume>, <fpage>570</fpage>–<lpage>573</lpage>.<pub-id pub-id-type="pmid">25011556</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
